Cargando…
Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
BACKGROUND: We aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS) per se affects the prevalence of left ventricular (LV) diastolic dysfunction in patients without comorbidities. METHODS: A total of 42 patients with first-diagnosed severe OSAS [apnea–hypopnea index (AHI...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769220/ https://www.ncbi.nlm.nih.gov/pubmed/31566076 http://dx.doi.org/10.1177/1753466619880076 |
_version_ | 1783455201971142656 |
---|---|
author | Papanikolaou, John Ntalapascha, Melpomeni Makris, Demosthenes Koukoubani, Triantafyllia Tsolaki, Vasiliki Zakynthinos, George Gourgoulianis, Konstantinos Zakynthinos, Epaminondas |
author_facet | Papanikolaou, John Ntalapascha, Melpomeni Makris, Demosthenes Koukoubani, Triantafyllia Tsolaki, Vasiliki Zakynthinos, George Gourgoulianis, Konstantinos Zakynthinos, Epaminondas |
author_sort | Papanikolaou, John |
collection | PubMed |
description | BACKGROUND: We aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS) per se affects the prevalence of left ventricular (LV) diastolic dysfunction in patients without comorbidities. METHODS: A total of 42 patients with first-diagnosed severe OSAS [apnea–hypopnea index (AHI) > 30] and 25 controls (AHI < 5), having been referred for snoring to the Sleep Laboratory Department of our tertiary Hospital, were enrolled in the study. Inclusion criteria were absence of any cardiovascular or oxidative stress-related comorbidities, and age between 20 and 70 years. Clinical, laboratory, echocardiographic, and polysomnographic data were recorded prospectively. Diastolic dysfunction diagnosis and grading was based on 2016 ASE/EACVI recommendations. RESULTS: Severe OSAS was associated with significantly increased prevalence and degree of diastolic dysfunction (26/42; 61.9%) compared with controls (7/25; 28%) (p = 0.007). AHI ⩾ 55 (dichotomous value of severe OSAS subset) was also characterized by greater prevalence and degree of diastolic dysfunction compared with 30 < AHI < 55 patients (p = 0.015). In the severe OSAS subset, age >45 years-old, height <1.745 m, body-mass index (BMI) >27.76 kg m(−2), OSAS severity (AHI > 57.35), oxidative stress (overnight reduction of reduced to oxidized glutathione ratio < 18.44%), and BMI/height ratio > 16.155 kg m(−3) (an index describing ‘dense’, short-heavy patients) presented significant diagnostic utility in identifying diastolic dysfunction in ROC-curve analysis (0.697 ⩾ AUC ⩾ 0.855, 0.001 ⩽ p ⩽ 0.018). In binary logistic regression model, advanced age (OR 1.23, 95% CI 1.025–1.477; p = 0.026) and AHI (OR 1.123, 95% CI 1.007–1.253; p = 0.036) showed independent association with diastolic dysfunction in severe OSAS. CONCLUSIONS: The present prospective study may suggest that severe OSAS is significantly associated with LV diastolic dysfunction; OSAS clinical severity exerts a positive influence on (and possibly constitutes an independent risk factor of) LV diastolic dysfunction. The reviews of this paper are available via the supplementary material section. |
format | Online Article Text |
id | pubmed-6769220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-67692202019-10-18 Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities Papanikolaou, John Ntalapascha, Melpomeni Makris, Demosthenes Koukoubani, Triantafyllia Tsolaki, Vasiliki Zakynthinos, George Gourgoulianis, Konstantinos Zakynthinos, Epaminondas Ther Adv Respir Dis Original Research BACKGROUND: We aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS) per se affects the prevalence of left ventricular (LV) diastolic dysfunction in patients without comorbidities. METHODS: A total of 42 patients with first-diagnosed severe OSAS [apnea–hypopnea index (AHI) > 30] and 25 controls (AHI < 5), having been referred for snoring to the Sleep Laboratory Department of our tertiary Hospital, were enrolled in the study. Inclusion criteria were absence of any cardiovascular or oxidative stress-related comorbidities, and age between 20 and 70 years. Clinical, laboratory, echocardiographic, and polysomnographic data were recorded prospectively. Diastolic dysfunction diagnosis and grading was based on 2016 ASE/EACVI recommendations. RESULTS: Severe OSAS was associated with significantly increased prevalence and degree of diastolic dysfunction (26/42; 61.9%) compared with controls (7/25; 28%) (p = 0.007). AHI ⩾ 55 (dichotomous value of severe OSAS subset) was also characterized by greater prevalence and degree of diastolic dysfunction compared with 30 < AHI < 55 patients (p = 0.015). In the severe OSAS subset, age >45 years-old, height <1.745 m, body-mass index (BMI) >27.76 kg m(−2), OSAS severity (AHI > 57.35), oxidative stress (overnight reduction of reduced to oxidized glutathione ratio < 18.44%), and BMI/height ratio > 16.155 kg m(−3) (an index describing ‘dense’, short-heavy patients) presented significant diagnostic utility in identifying diastolic dysfunction in ROC-curve analysis (0.697 ⩾ AUC ⩾ 0.855, 0.001 ⩽ p ⩽ 0.018). In binary logistic regression model, advanced age (OR 1.23, 95% CI 1.025–1.477; p = 0.026) and AHI (OR 1.123, 95% CI 1.007–1.253; p = 0.036) showed independent association with diastolic dysfunction in severe OSAS. CONCLUSIONS: The present prospective study may suggest that severe OSAS is significantly associated with LV diastolic dysfunction; OSAS clinical severity exerts a positive influence on (and possibly constitutes an independent risk factor of) LV diastolic dysfunction. The reviews of this paper are available via the supplementary material section. SAGE Publications 2019-09-30 /pmc/articles/PMC6769220/ /pubmed/31566076 http://dx.doi.org/10.1177/1753466619880076 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Papanikolaou, John Ntalapascha, Melpomeni Makris, Demosthenes Koukoubani, Triantafyllia Tsolaki, Vasiliki Zakynthinos, George Gourgoulianis, Konstantinos Zakynthinos, Epaminondas Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
title | Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
title_full | Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
title_fullStr | Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
title_full_unstemmed | Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
title_short | Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
title_sort | diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769220/ https://www.ncbi.nlm.nih.gov/pubmed/31566076 http://dx.doi.org/10.1177/1753466619880076 |
work_keys_str_mv | AT papanikolaoujohn diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT ntalapaschamelpomeni diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT makrisdemosthenes diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT koukoubanitriantafyllia diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT tsolakivasiliki diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT zakynthinosgeorge diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT gourgoulianiskonstantinos diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities AT zakynthinosepaminondas diastolicdysfunctioninmenwithsevereobstructivesleepapneasyndromebutwithoutcardiovascularoroxidativestressrelatedcomorbidities |